Inspire’s Denufosol shows efficacy in Phase III trials in Cystic Fibrosis

Inspire’s denufosol inhalation solution has shown efficacy in Phase III trials in Cystic Fibrosis. FEV1 of patients on denufosol improved compared to baseline while patients on placebo remained unchanged.